Azusa, CA, United States of America

Ryan Dellinger

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Irvine, CA (US) (2014)
  • Azusa, CA (US) (2018 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations by Ryan Dellinger: Patents and Contributions to Infant Health

Introduction

Ryan Dellinger, based in Azusa, CA, is an accomplished inventor with a remarkable portfolio of 18 patents. His work primarily focuses on advancements in health-related formulations, particularly in enhancing infant development and treating motor neuron diseases.

Latest Patents

Dellinger's latest patents encompass groundbreaking applications of compounds like nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide. These innovations are aimed at developing infant formula compositions that ensure healthy growth and development. In particular, one of his notable patents details methods for delivering key nutrients in combination with essential vitamins like thiamine, riboflavin, niacin, and pyridoxine to infants in need.

Additionally, Dellinger is pioneering methods and compositions to treat motor neuron diseases, including ALS. His research provides a promising avenue for therapeutic interventions by utilizing a combination of nicotinamide riboside, pterostilbene, and specific PDE inhibitors alongside thiol/cysteine donors.

Career Highlights

Throughout his career, Ryan Dellinger has made significant contributions while working with reputable companies such as Chromadex Inc. and Elysium Health, Inc. His expertise has allowed him to be at the forefront of innovative health solutions that address critical medical needs.

Collaborations

In the course of his career, Dellinger has collaborated with notable colleagues like Mark Morris and Troy Rhonemus. These partnerships have facilitated the advancement of his research and the development of impactful health products.

Conclusion

Ryan Dellinger's inventive spirit and commitment to enhancing health outcomes through innovative methodologies in infant formula and neurological treatment underscore his importance in the field. His achievements in securing 18 patents speak to his dedication and contribution to advancing healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…